Plant Comparison
Goldenseal vs Flaxseed
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Goldenseal and Flaxseed: they share 5 indicated uses (arthritis / joint pain, bloating, indigestion, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Goldenseal | Flaxseed | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 3/10 | Stronger for Goldenseal |
| Bloating | 5/10 | 3/10 | Stronger for Goldenseal |
| Indigestion | 5/10 | 3/10 | Stronger for Goldenseal |
| Inflammation (general) | 5/10 | 3/10 | Stronger for Goldenseal |
| Skin irritation | 5/10 | 3/10 | Stronger for Goldenseal |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.
Flax is the richest dietary source of SDG-type lignans, converted by gut bacteria to the mammalian lignans enterodiol and enterolactone; studied for antioxidant and hormone-modulating activity.
The dominant fatty acid of the seed oil (~50-55% of total oil), a plant-based omega-3 studied for cardiovascular and anti-inflammatory effects.
Concentrated in the seed coat; gives flaxseed its demulcent, laxative, bulk-forming action.
Present at low levels; cooking/roasting reduces them to negligible amounts in normal food use - a theoretical concern only at high raw intakes.
Pharmacological Actions
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.
Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.
Flaxseeds are safe for most people at recommended food amounts (1–2 tablespoons ground/day). They must be ground or milled to be bioavailable — whole seeds largely pass through the gut undigested. High fibre content may cause bloating, flatulence, and loose stools, especially if fibre intake is increased rapidly without adequate hydration. Flaxseeds contain cyanogenic glycosides (linamarin, linustatin); cooking or roasting reduces these to negligible levels in normal food amounts. Raw seeds in very large quantities are a theoretical concern, but typical use is safe (EFSA, 2017).
Medication interactions: Flaxseed may reduce absorption of oral medications if taken simultaneously — space flaxseed supplementation 1–2 hours from medications. Omega-3 ALA and lignans may mildly enhance anticoagulant/antiplatelet effects; use caution with blood thinners. Some sources suggest caution with hormone-sensitive conditions due to phytoestrogen (lignan) content, though dietary amounts are unlikely to pose risk (Adolphe et al., 2010).
Pregnancy: Food amounts are generally considered safe; high-dose supplements should be discussed with a clinician due to limited safety data.
Duke (2002) rates flaxseed as +++ with clinical evidence (score 2) for antiatherogenic, hypocholesterolemic, laxative, lipolytic (fat-dissolving), and demulcent activities. Flaxseed's omega-3 fatty acids (ALA) and lignans are associated with reduced cardiovascular risk. Commission E approves flaxseed as a laxative and for mucilaginous protection of inflamed gastrointestinal mucosa. Dose: 1–2 tablespoons ground seed with ample water, twice daily. Whole seeds should be chewed or ground for full medicinal effect. Cyanogenic glycosides are present but at safe levels in normal dietary amounts (Duke, 2002).
External Ids
Botanical Description
Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]
Erect annual herb, slender and often branched near the top, growing 30-80 (up to 100) cm tall from a fine taproot. Leaves are alternate, sessile, narrowly lanceolate to linear, blue-green and entire-margined. Flowers are pale blue (occasionally white or pink), five-petalled and borne on slender stalks in loose terminal cymes. The fruit is a small globular capsule ('boll') that splits into ten compartments, each containing one flattened, glossy, red-brown seed.[5]
Habitat
Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]
Native to the Mediterranean region and the Fertile Crescent, cultivated since prehistory for fibre and oil and now grown worldwide in temperate regions with well-drained, fertile soils and a cool, moist growing season; occasionally found as a naturalised escape on waste and cultivated ground.[5]
Harvesting
The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]
Grown as an annual crop, seed is harvested once the capsules ('bolls') have dried and turned brown, typically in late summer, by cutting or combining the whole plant and threshing out the seed. Whole seed stores well; it should only be ground shortly before use, since the oil in ground seed oxidises and turns rancid quickly.[2]
Traditional Uses
Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]
Flaxseed has a long history of traditional use as a bulk-forming laxative and demulcent for constipation and irritated gut mucosa, and as a poultice for boils and inflamed skin. Modern interest centres on its lignan (secoisolariciresinol diglucoside) and alpha-linolenic acid content, studied for cardiovascular, metabolic and hormone-related outcomes.[2, 4, 5]
Preparations
Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.
Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.
Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.
Whole seed freshly ground (milled) and taken with plenty of liquid, or stirred into food; grinding is needed to make the oil and lignans bioavailable, as whole seeds largely pass through the gut undigested.
Cold-pressed oil taken as a concentrated source of alpha-linolenic acid (omega-3); lacks the fibre and lignan content of the whole ground seed.
Dosage
The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.
Traditional guidance and Duke (2002) suggest 1-2 tablespoons of ground seed with ample water, once or twice daily. Educational reference only, not a prescription.
A randomised placebo-controlled trial titrated flax oil capsules (550 mg alpha-linolenic acid per 1 g of oil) to 12 capsules per day, i.e. up to roughly 12 g of oil daily, over 16 weeks - broadly matching the 1-2 tablespoons (about 10-15 mL) daily often cited for omega-3 intake. That trial was in children and adolescents with bipolar disorder and its primary outcomes were null; it is cited here only as a source for an administered human dose of the oil, not as evidence of benefit. Note the EU herbal monograph on Lini semen covers the SEED, not the oil. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
https://doi.org/10.1016/j.phrs.2020.105085 - Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth - Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
https://doi.org/10.1055/s-0030-1250606 - Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
https://doi.org/10.1055/s-0032-1315042 - Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
https://doi.org/10.1002/ptr.1108 - Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
https://doi.org/10.1021/np200336g - Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
https://doi.org/10.1021/acs.jnatprod.7b00654 - Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
https://doi.org/10.1016/j.phytol.2017.03.012 - Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
https://doi.org/10.1038/sj.clpt.6100222 - Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
https://doi.org/10.1016/j.fct.2018.07.033 - Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
https://doi.org/10.1016/j.fitote.2010.06.006 - Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
https://doi.org/10.1016/j.ejmech.2021.113839 - World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
https://doi.org/10.3109/00498251003592683 - Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
https://doi.org/10.1016/j.clpt.2005.01.009 - McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
https://doi.org/10.1124/dmd.120.091041 - Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
https://doi.org/10.1155/2021/2074610 - Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ - Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
https://doi.org/10.1001/archinte.157.17.2007 - North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/
- Picur, B., Cebrat, M., Zabrocki, J. and Siemion, I.Z (2006) 'Cyclopeptides of Linum usitatissimum', Journal of Peptide Science, 12(9), pp. 569-574. doi:10.1002/psc.779 Preclinical
https://doi.org/10.1002/psc.779 - Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., Smith, M., Szapary, P., Ulbricht, C., Vora, M. and Weissner, W (2007) 'Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration', Journal of the Society for Integrative Oncology, 5(3), pp. 92-105. doi:10.2310/7200.2007.005 Meta-analysis / review
https://doi.org/10.2310/7200.2007.005 - Chhillar, H., Chopra, P. and Ashfaq, M.A (2020) 'Lignans from linseed (Linum usitatissimum L.) and its allied species: retrospect, introspect and prospect', Critical Reviews in Food Science and Nutrition, 61(16), pp. 2719-2741. doi:10.1080/10408398.2020.1784840 Meta-analysis / review
https://doi.org/10.1080/10408398.2020.1784840 - Ansari, R., Zarshenas, M.M. and Dadbakhsh, A.H (2019) 'A review on pharmacological and clinical aspects of Linum usitatissimum L', Current Drug Discovery Technologies, 16(2), pp. 148-158. doi:10.2174/1570163815666180521101136 Meta-analysis / review
https://doi.org/10.2174/1570163815666180521101136 - Akter, Y., Junaid, M., Afrose, S.S., Nahrin, A., Alam, M.S., Sharmin, T., Akter, R. and Hosen, S.M.Z (2021) 'A comprehensive review on Linum usitatissimum medicinal plant: its phytochemistry, pharmacology, and ethnomedicinal uses', Mini Reviews in Medicinal Chemistry, 21(18), pp. 2801-2834. doi:10.2174/1389557521666210203153436 Meta-analysis / review
https://doi.org/10.2174/1389557521666210203153436 - Musazadeh, V., Abolghasemian, M., Kavyani, Z., Moridpour, A.H., Nazari, A. and Faghfouri, A.H (2024) 'The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: an updated systematic review and meta-analysis of randomized clinical trials', Complementary Therapies in Medicine, 84, pp. 103066. doi:10.1016/j.ctim.2024.103066 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2024.103066 - Mueed, A., Shibli, S., Jahangir, M., Jabbar, S. and Deng, Z (2022) 'A comprehensive review of flaxseed (Linum usitatissimum L.): health-affecting compounds, mechanism of toxicity, detoxification, anticancer and potential risk', Critical Reviews in Food Science and Nutrition, 63(32), pp. 11081-11104. doi:10.1080/10408398.2022.2092718 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2092718 - Kaithwas, G., Mukherjee, A., Chaurasia, A.K. and Majumdar, D.K (2011) 'Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil', Indian Journal of Experimental Biology, 49(12), pp. 932-938. Preclinical
https://scholar.google.com/scholar?q=Anti-inflammatory%2C%20analgesic%20and%20antipyretic%20activities%20of%20Linum%20usitatissimum%20L.%20%28flaxseed/linseed%29%20fixed%20oil - Rafieian-Kopaei, M., Shakiba, A., Sedighi, M. and Bahmani, M (2017) 'The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb/c mice', Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), pp. 892-896. doi:10.1177/2156587217717416 Preclinical
https://doi.org/10.1177/2156587217717416 - Sirotkin, A.V (2023) 'Influence of flaxseed (Linum usitatissimum) on female reproduction', Planta Medica, 89(6), pp. 608-615. doi:10.1055/a-2013-2966 Meta-analysis / review
https://doi.org/10.1055/a-2013-2966 - Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K. and Goss, P.E (2006) 'Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer', 11(10), pp. 3828--3835. doi:10.1158/1078-0432.CCR-04-2326 Randomized trial
https://doi.org/10.1158/1078-0432.CCR-04-2326 - Adolphe, J.L., Whiting, S.J., Juurlink, B.H.J., Thorpe, L.U. and Alcorn, J (2010) 'Health effects with consumption of the flax lignan secoisolariciresinol diglucoside', 103(7), pp. 929--938. doi:10.1017/S0007114509992753 Clinical study
https://doi.org/10.1017/S0007114509992753 - Caligiuri, S.P.B., Edel, A.L., Aliani, M. and Pierce, G.N (2014) 'Flaxseed for hypertension: implications for improved cardiovascular risk', 16(12), pp. 499. doi:10.1007/s11906-014-0499-8 Randomized trial
https://doi.org/10.1007/s11906-014-0499-8 - European Food Safety Authority (2017) 'Safety of cyanogenic glycosides from flaxseed consumed as part of a usual diet', 15(11). doi:10.2903/j.efsa.2017.5026 Preclinical
https://doi.org/10.2903/j.efsa.2017.5026 - Harris, W.S (2012) 'Stearidonic acid as a surrogate for eicosapentaenoic acid in cardiovascular risk reduction: update and recommendation', 70(10), pp. 565--574. Traditional / reference
https://scholar.google.com/scholar?q=Stearidonic%20acid%20as%20a%20surrogate%20for%20eicosapentaenoic%20acid%20in%20cardiovascular%20risk%20reduction%3A%20update%20and%20recommendation - Latvijas valsts mežzinātnes institūts (n.d.) 'Linsēkla Latvijā'. Available at: https://www.silava.lv Traditional / reference
https://www.silava.lv - Pan, A., Sun, J., Chen, Y. et al (2009) 'Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial', 4(11). doi:10.1371/journal.pone.0007654 Randomized trial
https://doi.org/10.1371/journal.pone.0007654 - Royal Botanic Gardens, Kew (n.d.) 'Linum usitatissimum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 - Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A. and Hibbeln, J.R (2010) 'Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder', Bipolar Disorders, 12(2), pp. 142-154. doi:10.1111/j.1399-5618.2010.00799.x Randomized trial
https://doi.org/10.1111/j.1399-5618.2010.00799.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.